stella
beta
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma — Stella
Recruiting
Back to Salivary Gland Neoplasm Duct trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
Peking University First Hospital, Beijing, Beijing Municipality
Peking University School and Hospital of Stomatology, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov